🔎 Trials Near Me

Utama › Obesiti › Virginia › Arlington

Kajian klinikal Obesiti di Arlington, VA

18 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Mengambil pesertaFasa 2
  • Washington Center For Weight Management And Research /ID# 282047, Arlington
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Mengambil pesertaFasa 2
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi jauh
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Mengambil pesertaFasa 3
  • Washington Cntr Weight Mgmt, Arlington
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07720271

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Mengambil pesertaFasa 3
  • Research Site, Manassas · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07776509

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Mengambil pesertaFasa 3
  • Washington Cntr Weight Mgmt, Arlington
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07339423

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Mengambil pesertaFasa 3
  • Research Site, Manassas · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Mengambil pesertaFasa 3
  • Virginia Heart, Falls Church · 4 mi jauh
  • Inova Cardiology - Fairfax, Fairfax · 11 mi jauh
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Mengambil pesertaFasa 3
  • Conquest Research, LLC, Arlington
  • Virginia Heart, Falls Church · 4 mi jauh
  • Carient Heart and Vascular, Manassas · 22 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Mengambil pesertaFasa 3
  • Manassas Clinical Research Center, Manassas · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
  • ACCOMPLISH-2 Research Site, Burke · 11 mi jauh
  • ACCOMPLISH-2 Research Site, Manassas · 22 mi jauh
Umur 18 hingga 79 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Mengambil pesertaFasa 3
  • Kailera Clinical Site, Manassas · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Mengambil pesertaFasa 3
  • Washington Center for Weight Management and Research, Inc, Arlington
Umur 18 hingga 99 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Mengambil pesertaFasa 3
  • Manassas Clinical Research Center Inc, Manassas · 22 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Mengambil pesertaFasa 3
  • Kailera Clinical Site, Manassas · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Mengambil pesertaFasa 3
  • Research Site, Arlington
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Mengambil pesertaFasa 3
  • Conquest Research, Vienna · 9 mi jauh
  • Carient Heart and Vascular, Manassas · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07567001

Brief Inhibitory Training for Eating - Intervention

Mengambil peserta
  • George Mason University, Fairfax · 11 mi jauh
Umur 14 hingga 17 · Semua jantina · Dikemas kini 17 Jun 2026 · NCT07592728

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
  • Vanda Investigational Site, Burke · 11 mi jauh
Umur 18 hingga 65 · Semua jantina · Dikemas kini 20 Apr 2026 · NCT07446439

Kajian Obesiti di bandar lain

Kajian lain di Arlington

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.